Anna Bergamaschi

4.4k total citations
42 papers, 2.7k citations indexed

About

Anna Bergamaschi is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Anna Bergamaschi has authored 42 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 18 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Anna Bergamaschi's work include Cancer Genomics and Diagnostics (10 papers), HIV Research and Treatment (6 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Anna Bergamaschi is often cited by papers focused on Cancer Genomics and Diagnostics (10 papers), HIV Research and Treatment (6 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Anna Bergamaschi collaborates with scholars based in United States, Italy and Norway. Anna Bergamaschi's co-authors include Benita S. Katzenellenbogen, Jonathan R. Pollack, Pei Wang, Gianfranco Pancino, Thérese Sørlie, Dong‐Young Noh, Wonshik Han, Annie David, Jie Peng and Per Eystein Lønning and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.

In The Last Decade

Anna Bergamaschi

41 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Bergamaschi United States 23 1.3k 694 645 490 362 42 2.7k
Mitchell Garber United States 14 2.6k 1.9× 418 0.6× 471 0.7× 472 1.0× 1.2k 3.3× 23 3.6k
Erich Huang United States 35 2.8k 2.1× 834 1.2× 1.4k 2.2× 698 1.4× 369 1.0× 74 5.6k
Shalini S. Yadav United States 21 840 0.6× 388 0.6× 940 1.5× 898 1.8× 275 0.8× 53 2.4k
Maciej Wiznerowicz Poland 25 3.7k 2.8× 1.4k 2.0× 873 1.4× 694 1.4× 124 0.3× 45 5.2k
Jennifer C. Boldrick United States 10 1.3k 1.0× 246 0.4× 452 0.7× 721 1.5× 19 0.1× 10 2.8k
Michael R. Savona United States 31 2.2k 1.7× 257 0.4× 773 1.2× 419 0.9× 271 0.7× 207 4.3k
Steve Goodison United States 46 3.2k 2.4× 1.2k 1.7× 1.5k 2.3× 724 1.5× 44 0.1× 159 6.1k
Karen Willard‐Gallo Belgium 36 1.3k 1.0× 471 0.7× 2.1k 3.2× 1.8k 3.7× 63 0.2× 139 4.3k
Stephen C. Schmechel United States 25 630 0.5× 205 0.3× 323 0.5× 200 0.4× 60 0.2× 44 1.8k
Martin E. van Royen Netherlands 29 1.7k 1.3× 465 0.7× 390 0.6× 190 0.4× 167 0.5× 83 2.9k

Countries citing papers authored by Anna Bergamaschi

Since Specialization
Citations

This map shows the geographic impact of Anna Bergamaschi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Bergamaschi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Bergamaschi more than expected).

Fields of papers citing papers by Anna Bergamaschi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Bergamaschi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Bergamaschi. The network helps show where Anna Bergamaschi may publish in the future.

Co-authorship network of co-authors of Anna Bergamaschi

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Bergamaschi. A scholar is included among the top collaborators of Anna Bergamaschi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Bergamaschi. Anna Bergamaschi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xue, Yuan, Glenn Oliveira, Verena Friedl, et al.. (2024). Analytical Validation of an Early Detection Pancreatic Cancer Test Using 5-Hydroxymethylation Signatures. Journal of Molecular Diagnostics. 26(10). 888–896. 4 indexed citations
2.
Haan, David, Anna Bergamaschi, Yuhong Ning, et al.. (2021). Genome-wide 5hmC profiles to enable cancer detection and tissue of origin classification in breast, colorectal, lung, ovarian, and pancreatic cancers.. Journal of Clinical Oncology. 39(15_suppl). 3044–3044. 1 indexed citations
3.
Guler, Gulfem D., Yuhong Ning, Chin‐Jen Ku, et al.. (2020). Detection of early stage pancreatic cancer using 5-hydroxymethylcytosine signatures in circulating cell free DNA. Nature Communications. 11(1). 5270–5270. 119 indexed citations
4.
Mir, Mustafa, Anna Bergamaschi, Benita S. Katzenellenbogen, & Gabriel Popescu. (2014). Highly Sensitive Quantitative Imaging for Monitoring Single Cancer Cell Growth Kinetics and Drug Response. PLoS ONE. 9(2). e89000–e89000. 48 indexed citations
5.
Bergamaschi, Anna, Jonna Frasor, Patricia A. Johnson, et al.. (2012). 14-3-3ζ as a predictor of early time to recurrence and distant metastasis in hormone receptor-positive and -negative breast cancers. Breast Cancer Research and Treatment. 137(3). 689–696. 20 indexed citations
6.
Bergamaschi, Anna & Benita S. Katzenellenbogen. (2011). Tamoxifen downregulation of miR-451 increases 14-3-3ζ and promotes breast cancer cell survival and endocrine resistance. Oncogene. 31(1). 39–47. 162 indexed citations
7.
Sáez‐Cirión, Asier, Anna Bergamaschi, Annie David, et al.. (2011). Restriction of HIV-1 replication in macrophages and CD4+ T cells from HIV controllers. Blood. 118(4). 955–964. 99 indexed citations
8.
Borrelli, Ivan, Stefania Loffredo, Rosaria Ilaria Staiano, et al.. (2010). Benzene Metabolites Inhibit the Release of Proinflammatory Mediators and Cytokines from Human Basophils. International Journal of Immunopathology and Pharmacology. 23(3). 737–744. 12 indexed citations
9.
Campagnolo, Luisa, Micol Massimiani, Andrea Magrini, et al.. (2010). Embryotoxicity of single wall carbon nanotubes: in vitro and in vivo studies. Cineca Institutional Research Information System (Tor Vergata University). 14–14. 1 indexed citations
10.
Bergamaschi, Anna, Geir Olav Hjortland, Tiziana Triulzi, et al.. (2009). Molecular profiling and characterization of luminal‐like and basal‐like in vivo breast cancer xenograft models. Molecular Oncology. 3(5-6). 469–482. 86 indexed citations
11.
Bocanegra, Melanie, Anna Bergamaschi, Y. H. Kim, et al.. (2009). Focal amplification and oncogene dependency of GAB2 in breast cancer. Oncogene. 29(5). 774–779. 56 indexed citations
12.
Bergamaschi, Anna, Young H. Kim, Kevin Kwei, et al.. (2008). CAMK1D amplification implicated in epithelial–mesenchymal transition in basal‐like breast cancer. Molecular Oncology. 2(4). 327–339. 43 indexed citations
13.
Bergamaschi, Anna, Elda Tagliabue, Thérese Sørlie, et al.. (2007). Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome. The Journal of Pathology. 214(3). 357–367. 297 indexed citations
14.
Casalini, Patrizia, Marilena V. Iorio, Valeria Berno, et al.. (2007). Relationship between p53 and p27 expression following HER2 signaling. The Breast. 16(6). 597–605. 16 indexed citations
15.
Baumbusch, Lars O., Simen Myhre, Anita Langerød, et al.. (2006). Expression of full-length p53 and its isoform Deltap53 in breast carcinomas in relation to mutation status and clinical parameters.. Molecular Cancer. 5(1). 47–47. 20 indexed citations
16.
Bergamaschi, Anna, Mauro Corsi, & Martine Garnier. (2006). Synergistic effects of cAMP-dependent signalling pathways and IL-1 on IL-6 production by H19-7/IGF-IR neuronal cells. Cellular Signalling. 18(10). 1679–1684. 18 indexed citations
17.
Bergamaschi, Anna, Young Ho Kim, Pei Wang, et al.. (2006). Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene‐expression subtypes of breast cancer. Genes Chromosomes and Cancer. 45(11). 1033–1040. 368 indexed citations
18.
Manfredini, Rossella, Elena Tenedini, M Siena, et al.. (2003). Development of an IL-6 antagonist peptide that induces apoptosis in 7TD1 cells. Peptides. 24(8). 1207–1220. 10 indexed citations
19.
Iervolino, Angela, Giorgia Santilli, Rossana Trotta, et al.. (2002). hnRNP A1 Nucleocytoplasmic Shuttling Activity Is Required for Normal Myelopoiesis and BCR/ABL Leukemogenesis. Molecular and Cellular Biology. 22(7). 2255–2266. 100 indexed citations
20.
Tagliafico, Enrico, Elena Tenedini, Anna Bergamaschi, et al.. (2002). Gene expression profile of Vitamin D3 treated HL60 cells shows an incomplete molecular phenotypic conversion to monocytes. Cell Death and Differentiation. 9(11). 1185–1195. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mitchell Garber Breakdown of academic impact, for papers by Erich Huang Breakdown of academic impact, for papers by Shalini S. Yadav Breakdown of academic impact, for papers by Maciej Wiznerowicz Breakdown of academic impact, for papers by Jennifer C. Boldrick Breakdown of academic impact, for papers by Michael R. Savona Breakdown of academic impact, for papers by Steve Goodison Breakdown of academic impact, for papers by Karen Willard‐Gallo Breakdown of academic impact, for papers by Stephen C. Schmechel Breakdown of academic impact, for papers by Martin E. van Royen
Rankless by CCL
2026